[HTML] sciencedirect.com

[HTML][HTML] Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543

X Yi, X Tang, T Li, L Chen, H He, X Wu, C Xiang… - Biomedicine & …, 2023 - Elsevier
PF-543 is a sphingosine kinase 1 (SPHK1) inhibitor developed by Pfizer and is currently
considered the most potent selective SPHK1 inhibitor. SPHK1 catalyses the production of …
被引用次数：5 相关文章

Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543

X Yi, X Tang, T Li, L Chen, H He, X Wu… - Biomedicine & … - pubmed.ncbi.nlm.nih.gov
PF-543 is a sphingosine kinase 1 (SPHK1) inhibitor developed by Pfizer and is currently
considered the most potent selective SPHK1 inhibitor. SPHK1 catalyses the production of …

Therapeutic potential of the sphingosine kinase 1 inhibitor, PF-543.

X Yi, X Tang, T Li, L Chen, H He, X Wu… - Biomedicine & …, 2023 - europepmc.org
PF-543 is a sphingosine kinase 1 (SPHK1) inhibitor developed by Pfizer and is currently
considered the most potent selective SPHK1 inhibitor. SPHK1 catalyses the production of …